🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to estimate the relative bioavailability of ni...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2022-08-31
Trial ID
NCT05525910
Study in healthy males to assess bioavailability of 4 different fostamatini...
Status
Completed
Location
Research Site
Start Date
2011-08
Trial ID
NCT01387308
Treatments Being Tested
The goal of this study is to learn what happens to enlicitide (MK-0616) in ...
Status
Completed
Location
Celerion ( Site 0001)
Start Date
2026-03-23
Trial ID
NCT07481708
Treatments Being Tested
This study is designed to compare the pharmacokinetics of three different f...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-01
Trial ID
NCT01513928
Treatments Being Tested
The purpose of this study is to assess the bioavailability of four experime...
Status
Completed
Location
Mds Pharma Services (Us) Inc.
Start Date
2009-05
Trial ID
NCT00901498
Treatments Being Tested
Debio 1450-103 is a trial to study the pharmacokinetics (PK) of an experime...
Status
Completed
Location
Early Phase Clinical Unit
Start Date
2014-08
Trial ID
NCT02214433
The primary goal of this study is to evaluate the safety and reactogenicity...
Status
Completed
Location
Accel Research Sites
Start Date
2022-10-14
Trial ID
NCT05585632
Treatments Being Tested
To evaluate the dose proportionality of 5 mg, 20 mg and 40 mg of PF 0034543...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-04
Trial ID
NCT02089295
An open-label, randomized, three-period, three-way crossover trial of singl...
Status
Completed
Location
Worldwide Clinical Trials Early Phase Services, LLC
Start Date
2016-11
Trial ID
NCT02962531
The objective of this study is to evaluate the bioavailability of risankizu...
Status
Completed
Location
Acpru /Id# 210844
Start Date
2019-04-02
Trial ID
NCT05283681
Treatments Being Tested